rs199857233

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001305581.2(LRMDA):​c.336C>T​(p.Asn112Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000581 in 1,614,006 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00049 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00059 ( 3 hom. )

Consequence

LRMDA
NM_001305581.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.62

Publications

0 publications found
Variant links:
Genes affected
LRMDA (HGNC:23405): (leucine rich melanocyte differentiation associated) This gene encodes a leucine-rich repeat protein. The encoded protein is thought to play a role in melanocyte differentiation. Mutations in this gene have been associated with autosomal recessive oculocutaneous albinism 7 (OCA7). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Mar 2015]
LRMDA Gene-Disease associations (from GenCC):
  • oculocutaneous albinism type 7
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 10-76047241-C-T is Benign according to our data. Variant chr10-76047241-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261989.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.62 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000486 (74/152280) while in subpopulation SAS AF = 0.00311 (15/4820). AF 95% confidence interval is 0.00192. There are 0 homozygotes in GnomAd4. There are 37 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRMDANM_001305581.2 linkc.336C>T p.Asn112Asn synonymous_variant Exon 4 of 7 ENST00000611255.5 NP_001292510.1 A0A087WWI0
LRMDANM_032024.5 linkc.252C>T p.Asn84Asn synonymous_variant Exon 3 of 6 NP_114413.1 Q9H2I8
LRMDANR_131178.2 linkn.690C>T non_coding_transcript_exon_variant Exon 5 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRMDAENST00000611255.5 linkc.336C>T p.Asn112Asn synonymous_variant Exon 4 of 7 5 NM_001305581.2 ENSP00000480240.1 A0A087WWI0
LRMDAENST00000372499.5 linkc.252C>T p.Asn84Asn synonymous_variant Exon 3 of 6 1 ENSP00000361577.1 Q9H2I8
LRMDAENST00000593699.5 linkn.690C>T non_coding_transcript_exon_variant Exon 5 of 8 1

Frequencies

GnomAD3 genomes
AF:
0.000486
AC:
74
AN:
152162
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.000566
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000705
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000888
AC:
223
AN:
251178
AF XY:
0.00123
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.000722
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.000590
AC:
863
AN:
1461726
Hom.:
3
Cov.:
30
AF XY:
0.000774
AC XY:
563
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33462
American (AMR)
AF:
0.000134
AC:
6
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.000459
AC:
12
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39692
South Asian (SAS)
AF:
0.00382
AC:
329
AN:
86226
European-Finnish (FIN)
AF:
0.000337
AC:
18
AN:
53420
Middle Eastern (MID)
AF:
0.00538
AC:
31
AN:
5766
European-Non Finnish (NFE)
AF:
0.000377
AC:
419
AN:
1111924
Other (OTH)
AF:
0.000695
AC:
42
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
41
82
123
164
205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000486
AC:
74
AN:
152280
Hom.:
0
Cov.:
33
AF XY:
0.000497
AC XY:
37
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41550
American (AMR)
AF:
0.0000654
AC:
1
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4820
European-Finnish (FIN)
AF:
0.000566
AC:
6
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000706
AC:
48
AN:
68036
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000426
Hom.:
0
Bravo
AF:
0.000336
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000818
EpiControl
AF:
0.000949

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 07, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Dec 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
2.0
DANN
Benign
0.61
PhyloP100
-1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199857233; hg19: chr10-77806999; API